Comparison of various pharmaceutical properties of clobetasol propionate cream formulations - considering stability of mixture with moisturizer.
Clobetasol propionate
Cream
Generic
Mixture
Near infrared spectroscopy
Rheological property
TG-DTA
Journal
Journal of pharmaceutical health care and sciences
ISSN: 2055-0294
Titre abrégé: J Pharm Health Care Sci
Pays: England
ID NLM: 101672177
Informations de publication
Date de publication:
2020
2020
Historique:
received:
21
10
2019
accepted:
20
01
2020
entrez:
5
2
2020
pubmed:
6
2
2020
medline:
6
2
2020
Statut:
epublish
Résumé
The clobetasol propionate cream formulations (CLB Pharmaceutical properties of CLB The hardness of Dermovate® (DRM), Glydil® (GDL), and Myalone® (MYA) was greater than that of CLB Thus, even for cream formulations with the same active pharmaceutical ingredient, pharmaceutical properties and stability of mixture with moisturizer may different significantly.
Sections du résumé
BACKGROUND
BACKGROUND
The clobetasol propionate cream formulations (CLB
METHOD
METHODS
Pharmaceutical properties of CLB
RESULTS
RESULTS
The hardness of Dermovate® (DRM), Glydil® (GDL), and Myalone® (MYA) was greater than that of CLB
CONCLUSION
CONCLUSIONS
Thus, even for cream formulations with the same active pharmaceutical ingredient, pharmaceutical properties and stability of mixture with moisturizer may different significantly.
Identifiants
pubmed: 32015896
doi: 10.1186/s40780-020-0158-y
pii: 158
pmc: PMC6990562
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1Informations de copyright
© The Author(s). 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interest.
Références
Chem Pharm Bull (Tokyo). 2015;63(1):43-8
pubmed: 25400272
Int J Pharm. 2014 Mar 10;463(1):62-7
pubmed: 24406671
Talanta. 2013 Nov 15;116:65-70
pubmed: 24148374
Chem Pharm Bull (Tokyo). 2015;63(5):377-83
pubmed: 25948331
J Am Acad Dermatol. 1993 Aug;29(2 Pt 1):197-202
pubmed: 8335738
Eur J Pharm Sci. 2018 Nov 1;124:199-207
pubmed: 30171983
Chem Pharm Bull (Tokyo). 2016 Jul 1;64(7):1047-55
pubmed: 27109377
Chem Pharm Bull (Tokyo). 2012;60(2):260-6
pubmed: 22293488
J Biosci Bioeng. 2008 Dec;106(6):537-40
pubmed: 19134547
Int J Pharm. 2012 Apr 15;426(1-2):54-60
pubmed: 22286017
Spectrochim Acta A Mol Biomol Spectrosc. 2010 May;75(5):1535-9
pubmed: 20299275
J Dent Res. 1992 Mar;71(3):438-42
pubmed: 1573074
Drug Dev Ind Pharm. 2010 Jun;36(6):625-31
pubmed: 19954404
Chem Pharm Bull (Tokyo). 2012;60(5):624-31
pubmed: 22689400
J Pharm Biomed Anal. 2017 Aug 5;142:178-189
pubmed: 28514717
Results Pharma Sci. 2013 Nov 06;3:15-9
pubmed: 25756000
Skin Pharmacol Physiol. 2009;22(3):142-50
pubmed: 19246962
J Sci Food Agric. 2014 Mar 30;94(5):1026-33
pubmed: 23983143
Chem Pharm Bull (Tokyo). 2015;63(9):663-8
pubmed: 26329859
Pharmazie. 2014 Feb;69(2):104-8
pubmed: 24640598
Int J Pharm. 2005 Dec 8;306(1-2):56-70
pubmed: 16266793
Int J Pharm. 2013 May 1;448(1):305-12
pubmed: 23541986